Vishwajit Nimgaonkar, Md Phd
Clinical trials sponsored by Vishwajit Nimgaonkar, Md Phd, explained in plain language.
-
Old drug, new hope: could acetazolamide ease tough schizophrenia symptoms?
Symptom relief Recruiting nowThis study tests whether acetazolamide, a drug currently used for altitude sickness and glaucoma, can reduce positive symptoms (like hallucinations or delusions) in people with treatment-resistant schizophrenia. Sixty adults aged 18-55 who still have significant symptoms despite …
Phase: PHASE1, PHASE2 • Sponsor: Vishwajit Nimgaonkar, MD PhD • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Could a common allergy spray help schizophrenia?
Symptom relief Recruiting nowThis study tests whether cromoglicate, a nasal spray used for allergies, can improve symptoms in people with schizophrenia or schizoaffective disorder. Researchers will give 160 adults either the active spray or a placebo, in addition to their usual medication. The goal is to see…
Phase: PHASE1, PHASE2 • Sponsor: Vishwajit Nimgaonkar, MD PhD • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC